Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
ES07 - Grief and Loss in Palliative Care*
- 09:45 - 10:20
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Palliative and Supportive Care
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Andreas Charalambous
-
+
ES07.01 - Grief and Loss for the Patient
09:45 - 09:47 | Presenter: Celia Marston
- Abstract
No abstract available for this presentation
-
+
ES07.02 - Non-pharmacologic Interventions for Physical Symptoms
09:47 - 09:49 | Presenter: Alex Molassiotis
- Abstract
No abstract available for this presentation
-
+
ES07.03 - Psychosocial Interventions for Patients
09:49 - 09:51 | Presenter: Gary Rodin
- Abstract
No abstract available for this presentation
-
+
ES07.04 - Communication in Palliative Care Settings
09:51 - 09:53 | Presenter: Rachelle Bernacki
- Abstract
No abstract available for this presentation
-
+
ES07.05 - Grief and Loss for Clinicians and Clinician Self-care
09:53 - 09:55 | Presenter: Sonia Patricia Oyola
- Abstract
No abstract available for this presentation
-
+
ES07.06 - Live Discussion with Speakers
09:55 - 10:20
- Abstract
No abstract available for this presentation
-
+
ES08 - What has COVID-19 Taught Us About Improving Management of Treatment for Patients with Lung Cancer*
- 10:30 - 11:05
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Management of Lung Cancer in the Era of COVID-19
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Amy C. Moore, Fred R Hirsch
-
+
ES08.01 - COVID-19 Vaccines
10:30 - 10:32 | Presenter: Anne-Marie Dingemans
- Abstract
No abstract available for this presentation
-
+
ES08.02 - What has COVID-19 Taught Us About Improving Management of Treatment for Patients with Lung Cancer
10:32 - 10:34 | Presenter: Gilberto Lopes
- Abstract
No abstract available for this presentation
-
+
ES08.03 - Long-Term Outcomes
10:34 - 10:36 | Presenter: Annalisa Trama
- Abstract
No abstract available for this presentation
-
+
ES08.04 - COVID-19 in Lower and Middle-Income Countries
10:36 - 10:38 | Presenter: Luis Corrales
- Abstract
No abstract available for this presentation
-
+
ES08.05 - Live Discussion with Speakers
10:38 - 11:05
- Abstract
No abstract available for this presentation
-
+
ES09 - Pathology Assessment and Biomarker Testing: Implications of and for Adjuvant and Neoadjuvant Therapy*
- 10:30 - 11:05
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Dara Aisner, Wendy Cooper
-
+
ES09.01 - Adjuvant and Neoadjuvant Therapy for NSCLC – Current and Future Perspectives
10:30 - 10:32 | Presenter: Daniel Tan
- Abstract
No abstract available for this presentation
-
+
ES09.02 - Pathological Assessment Following Neoadjuvant Therapy: Challenges and Pitfalls
10:32 - 10:34 | Presenter: Sanja Dacic
- Abstract
No abstract available for this presentation
-
+
ES09.03 - The Role of Biomarkers for Immunotherapy in the Adjuvant and Neoadjuvant Setting
10:34 - 10:36 | Presenter: Francois Ghiringhelli
- Abstract
Loading... -
+
ES09.04 - The Role of Biomarkers for Targeted Therapy in the Adjuvant and Neoadjuvant Setting
10:36 - 10:38 | Presenter: Fernando Lopez-Rios
- Abstract
No abstract available for this presentation
-
+
ES09.05 - Facilitating Biomarker Discovery in the Adjuvant and Neoadjuvant Setting
10:38 - 10:40 | Presenter: Janis M Taube
- Abstract
No abstract available for this presentation
-
+
ES09.06 - Tobacco Moment: The Criticality of Development of a Validated Tobacco Use Measurement Tool in Clinical Trials (Captured, Considered in Clinical Endpoints and Final Analysis)
10:40 - 10:43 | Presenter: Carolyn Dresler
- Abstract
No abstract available for this presentation
-
+
ES09.07 - Live Discussion with Speakers
10:43 - 11:05
- Abstract
No abstract available for this presentation
-
+
ES10 - Optimizing Clinical Outcomes in Lung Cancer: The Value of Tobacco Cessation*
- 11:15 - 11:50
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Risk Reduction and Tobacco Control
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Meredith Giuliani, Antonella Cardone
-
+
ES10.01 - Biologic and Translational Considerations of Tobacco Use Related to Therapeutic Outcomes
11:15 - 11:17 | Presenter: Graham Warren
- Abstract
No abstract available for this presentation
-
+
ES10.03 - Impact of Smoking on Clinical Outcomes of Radiotherapy
11:17 - 11:19 | Presenter: Jacek Jassem
- Abstract
No abstract available for this presentation
-
+
ES10.04 - Smoking and Cancer Clinical Trials
11:19 - 11:21 | Presenter: Bill Kenneth Evans
- Abstract
No abstract available for this presentation
-
+
ES10.05 - Tobacco Dependence Treatment Guideline Update (American Thoracic Society Tobacco Treatment Guidelines released in 2020)
11:21 - 11:24 | Presenter: Frank Leone
- Abstract
No abstract available for this presentation
-
+
ES10.06 - Live Discussion with Speakers
11:24 - 11:50
- Abstract
No abstract available for this presentation
-
+
ES11 - Small Cell Lung Cancer: Recent Preclinical Advances and Emerging Approaches to Therapy*
- 11:15 - 11:50
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Small Cell Lung Cancer/ NET
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Ticiana Leal, J.T. Poirier
-
+
ES11.01 - SCLC Subgroups and Their Potential Clinical Significance
11:15 - 11:17 | Presenter: Carl Gay
- Abstract
No abstract available for this presentation
-
+
ES11.02 - Advances in Thoracic Radiation in SCLC
11:17 - 11:19 | Presenter: Bjørn Henning Grønberg
- Abstract
Loading... -
+
ES11.03 - Emerging Strategies in ES-SCLC in the Frontline
11:19 - 11:21 | Presenter: Qing Zhou
- Abstract
Loading... -
+
ES11.04 - Treatment Options for Second-line and Beyond in ES-SCLC
11:21 - 11:23 | Presenter: Victoria Lai
- Abstract
No abstract available for this presentation
-
+
ES11.05 - Mechanisms of Resistance in SCLC
11:23 - 11:25 | Presenter: Lauren Averett Byers
- Abstract
No abstract available for this presentation
-
+
ES11.06 - Live Discussion with Speakers
11:25 - 11:50
- Abstract
No abstract available for this presentation
-
+
BEDG01 - Meet the Nurse and Allied Health Committee
- 12:00 - 13:00
- 9/10/2021
- Location: Brain Exchange Lounge
- Not for CME Credit
- Type: Brain Exchange Discussion Groups
- Track: N.A.
-
+
BEDG01.01 - Join the IASLC Nurse and Allied Health Committee for an Interactive Discussion about How to Build Your Career, Finding and Being a Good Mentor, Best Practices for the Field, Why Being Involved in IASLC Helped Their Careers, and So Much More
12:00 - 13:00 | Presenter: Morten Quist, Melissa Jane Culligan, Csaba Laszlo Degi, Michelle Turner
- Abstract
No abstract available for this presentation
-
+
BEDG02 - Lung Ambition Alliance with AstraZeneca - Accelerating the Early Diagnosis of Lung Cancer at Local Level
- 12:00 - 13:00
- 9/10/2021
- Location: Brain Exchange Lounge
- Not for CME Credit
- Type: Brain Exchange Discussion Groups
- Track: N.A.
- Moderators:Giorgio Vittorio Scagliotti, Ugo Pastorino, Stephen Lam, Joachim G.J.V. Aerts, Mozziyar Etemadi, Raymond Uyiosa Osarogiagbon
-
+
BEDG02.01 - Welcome, Introductions and Session Overview
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG02.02 - Time for Screening of Lung Cancer is Now
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG02.03 - Challenges in LCS: How to Overcome Them
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG02.04 - IPN Detection as a Complementary Strategy
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG02.05 - Potential of AI in Early Lung Cancer Detection
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG02.06 - Case Studies/Best Practices
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG02.07 - Discussion/Q&A
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG03 - Sip and Chat with the FDA
- 12:00 - 13:00
- 9/10/2021
- Location: Brain Exchange Lounge
- Not for CME Credit
- Type: Brain Exchange Discussion Groups
- Track: N.A.
-
+
BEDG03.01 - Early Stage Trials and Recent Approvals
12:00 - 12:00 | Presenter: Erin Larkins, Nicole Drezner, Paz Vellanki
- Abstract
No abstract available for this presentation
-
+
BEDG03.02 - Endpoints & Path CR
12:00 - 12:00 | Presenter: Erin Larkins, Nicole Drezner, Paz Vellanki
- Abstract
No abstract available for this presentation
-
+
BEDG03.03 - Precision Medicine
12:00 - 12:00 | Presenter: Erin Larkins, Nicole Drezner, Paz Vellanki
- Abstract
No abstract available for this presentation
-
+
BEDG04 - Brain Exchange Session by AstraZeneca: 'Defining Cure’ in Stage III Unresectable NSCLC. Management to Long Term Survivors
- 12:00 - 13:00
- 9/10/2021
- Location: Brain Exchange Lounge
- Not for CME Credit
- Type: Brain Exchange Discussion Groups
- Track: N.A.
- Moderators:Suresh Ramalingam
-
+
BEDG04.01 - Defining “Cure” in Long Term Survivors in Early Stage Lung Cancer. Current Definition of Cure in NSCLC Clinical Practice
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG04.02 - Identification and Management/Surveillance of Patients with Early Stage Who Achieve Long-Term Survival
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG05 - Brain Exchange Session by Oncocyte: Management of Early-Stage NSCLC
- 12:00 - 13:00
- 9/10/2021
- Location: Brain Exchange Lounge
- Not for CME Credit
- Type: Brain Exchange Discussion Groups
- Track: N.A.
- Moderators:Sara Riordan
-
+
BEDG05.01 - Frequency of Oncologists Managing Early-Stage NSCLC
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG05.02 - Current Molecular Landscape for Patients with Early-Stage NSCLC
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG05.03 - The Multidisciplinary Approach to Managing NSCLC
12:00 - 12:00
- Abstract
No abstract available for this presentation
-
+
BEDG05.04 - Assessment of Current and Prospective Treatments for Early-Stage NSCLC - How Do These Advancements in Therapy Change How the Patient Is Treated?
12:00 - 12:00
- Abstract
No abstract available for this presentation
first
prev